December 23, 2020

Employers find testing employees more trouble than it’s worth

Testing is “not a solution you can do for every employee, every day”

Mass testing, a critical tool to stem the virus’s spread, would appear an obvious solution.

But dogged by issues of cost — diagnostic tests start at around $100 each — access, logistics and employee privacy, tests aren’t part of most back-to-work plans. As health-care companies that work with employers in this capacity are fond of saying, there’s no silver bullet.

Another major deterrent is that Covid-19 tests only measure that point in time, notes Lauren Vela, senior director for the Pacific Business Group on Health, in this Bloomberg article.  If a worker is infected shortly after being tested, it wouldn’t show up but everyone would be falsely reassured by the negative result.

Read the full Bloomberg article here

Read about Employers find testing employees more trouble than it’s worth via Bloomberg   (opens in new window)